Scale-up of collaborative TB/HIV activities in Guyana
- PMID: 28444006
- PMCID: PMC6660869
- DOI: 10.26633/RPSP.2017.6
Scale-up of collaborative TB/HIV activities in Guyana
Abstract
Objective: To assess scale-up of recommended tuberculosis (TB)/HIV activities in Guyana and to identify specific strategies for further expansion.
Methods: Medical records and clinic registers were reviewed at nine TB clinics and 10 HIV clinics. At TB clinics, data were collected on HIV testing and antiretroviral therapy (ART) for patients with TB/HIV; at HIV clinics, data were collected on intensified case finding (ICF), tuberculin skin test (TST) results, and provision of isoniazid preventive therapy (IPT).
Results: At TB clinics, among 461 patients newly diagnosed with TB, 419 (90.9%) had a known HIV status and 121 (28.9%) were HIV-infected. Among the 63 patients with TB/HIV, 33 (52.4%) received ART. Among the 45 patients with TB/HIV for whom dates of HIV diagnosis were available, 38 (84.4%) individuals knew their HIV status prior to TB diagnosis. At HIV clinics, among 127 patients eligible to receive a TST, 87 (68.5%) received a TST, 66 (75.9%) had a TST result, seven (10.6%) had a newly positive result, two had a previously positive result, and six of nine patients with positive results (66.7%) received IPT. ICF could not be assessed because of incomplete or discrepant documentation.
Conclusions: An in-depth evaluation of TB/HIV activities successfully identified areas of success and remaining challenges. At TB clinics, HIV testing rates are high; further scale-up of ART for persons with TB/HIV is needed. At HIV clinics, use of TST to focus IPT is a feasible and efficient strategy; improving rates of annual TST screening will allow for further expansion of IPT.
Objetivo.: Evaluar la ampliación de las actividades recomendadas contra la tuberculosis (TB) y la infección por el VIH en Guyana y definir estrategias específicas para nuevas expansiones.
Métodos.: Se examinaron los expedientes médicos y registros clínicos de nueve consultorios de atención de la TB y diez consultorios de atención de la infección por el VIH. En los consultorios de atención de la tuberculosis, se recopilaron datos sobre las pruebas de detección del VIH y el tratamiento antirretroviral (TAR) para pacientes con TB e infección por el VIH; en los consultorios de atención de la infección por VIH, se recopilaron datos a partir de una búsqueda intensiva de casos, los resultados de la prueba de la tuberculina y la provisión de tratamiento preventivo con isoniazida.
Resultados.: En los consultorios de atención de la tuberculosis, de 461 pacientes recién diagnosticados con tuberculosis, 419 (90,9%) conocían su estado con respecto a la infección por el VIH y 121 (28,9%) estaban infectados por el virus. De los 63 pacientes con TB e infección por el VIH, 33 (52,4%) recibieron TAR. De los 45 pacientes con TB e infección por el VIH cuya fecha de diagnóstico de la infección por el VIH se conocía, 38 (84,4%) supieron de su estado con respecto a la infección por el VIH antes de recibir el diagnóstico de la tuberculosis. En los consultorios de atención de la infección por el VIH, de 127 pacientes que reunían los requisitos para la prueba de la tuberculina, 87 (68,5%) recibieron la prueba, 66 (75,9%) tuvieron un resultado, siete (10,6%) tuvieron un resultado positivo nuevo, dos habían tenido un resultado positivo anteriormente, y seis de nueve pacientes con resultados positivos (66,7%) recibieron tratamiento preventivo con isoniazida. No pudo evaluarse la búsqueda intensiva de casos debido a que la documentación estaba incompleta o era discrepante.
Conclusiones.: Una evaluación exhaustiva de las actividades contra la TB y la infección por el VIH permitió determinar las áreas donde se había tenido éxito y los retos pendientes. En los consultorios de atención de la tuberculosis, las tasas de realización de pruebas de detección del VIH son elevadas; se necesita ampliar el alcance del TAR para llegar a las personas con TB e infección por el VIH. En los consultorios de atención de la infección por el VIH, el uso de la prueba de la tuberculina para focalizar la búsqueda intensiva de casos es una estrategia factible y eficaz; el mejoramiento de las tasas de tamizaje anual con la prueba de la tuberculina permitirá ampliar la búsqueda intensiva de casos.
Conflict of interest statement
None.
Figures

Similar articles
-
The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB/HIV in Rio (THRio) study.AIDS. 2010 Nov;24 Suppl 5(Suppl 5):S49-56. doi: 10.1097/01.aids.0000391022.95412.a6. AIDS. 2010. PMID: 21079428 Free PMC article. Clinical Trial.
-
Brief Report: Yield of Repeat Tuberculin Skin Testing for People Living With HIV in Brazil.J Acquir Immune Defic Syndr. 2021 Dec 1;88(4):329-332. doi: 10.1097/QAI.0000000000002779. J Acquir Immune Defic Syndr. 2021. PMID: 34334739 Free PMC article.
-
Implementation and Operational Research: Feasibility of Using Tuberculin Skin Test Screening for Initiation of 36-Month Isoniazid Preventive Therapy in HIV-Infected Patients in Resource-Constrained Settings.J Acquir Immune Defic Syndr. 2016 Apr 1;71(4):e89-95. doi: 10.1097/QAI.0000000000000895. J Acquir Immune Defic Syndr. 2016. PMID: 26910386
-
Review of policy and status of implementation of collaborative HIV-TB activities in 23 high-burden countries.Int J Tuberc Lung Dis. 2014 Oct;18(10):1149-58. doi: 10.5588/ijtld.13.0889. Int J Tuberc Lung Dis. 2014. PMID: 25216827 Review.
-
Tuberculosis preventive therapy: an underutilised strategy to reduce individual risk of TB and contribute to TB control.S Afr Med J. 2014 Apr 16;104(5):339-43. doi: 10.7196/samj.8290. S Afr Med J. 2014. PMID: 25212199 Review.
Cited by
-
The latent tuberculosis cascade-of-care among people living with HIV: A systematic review and meta-analysis.PLoS Med. 2021 Sep 7;18(9):e1003703. doi: 10.1371/journal.pmed.1003703. eCollection 2021 Sep. PLoS Med. 2021. PMID: 34492003 Free PMC article.
References
-
- World Health Organization . Geneva: WHO; 2015. [Accessed on 29 November 2016.]. Global tuberculosis report 2015. Available from: http://apps.who.int/iris/bitstream/10665/191102/1/9789241565059_eng.pdf.
- 1. World Health Organization. Global tuberculosis report 2015. Geneva: WHO; 2015. Available from: http://apps.who.int/iris/bitstream/10665/191102/1/9789241565059_eng.pdf Accessed on 29 November 2016.
-
- Guyana Ministry of Health. Guyana AIDS response progress report . Georgetown: MoH; 2015. [Accessed on 25 January 2016.]. Republic of Guyana/Reporting period January– December 2014. Available from: http://www.unaids.org/en/dataanalysis/knowyourresponse/countryprogressre....
- 2. Guyana Ministry of Health. Guyana AIDS response progress report. Republic of Guyana/Reporting period January– December 2014. Georgetown: MoH; 2015. Available from: http://www.unaids.org/en/dataanalysis/knowyourresponse/countryprogressre... Accessed on 25 January 2016.
-
- World Health Organization . Geneva: WHO; 2016. [Accessed on 25 January 2016.]. Guyana country profile 2014: tuberculosis. Available from: https://extranet.who.int/sree/Reports?op=Replet&name=%2FWHO_HQ_Reports%2....
- 3. World Health Organization. Guyana country profile 2014: tuberculosis. Geneva: WHO; 2016. Available from: https://extranet.who.int/sree/Reports?op=Replet&name=%2FWHO_HQ_Reports%2... Accessed on 25 January 2016.
-
- U.S. Centers for Disease Control and Prevention HIV counseling, testing, and care of tuberculosis patients at chest clinics— Guyana, 2005–2006. [Accessed on 25 January 2016.];MMWR Morb Mortal Wkly Rep. 2006 55(31):849–851. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5531a3.htm. - PubMed
- 4. U.S. Centers for Disease Control and Prevention. HIV counseling, testing, and care of tuberculosis patients at chest clinics— Guyana, 2005–2006. MMWR Morb Mortal Wkly Rep. 2006;55(31):849–51. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5531a3.htm Accessed on 25 January 2016. - PubMed
-
- World Health Organization . Geneva: WHO; 2012. [Accessed on 25 January 2016.]. WHO policy on collaborative TB/HIV activities: guidelines for national programmes and other stakeholders. Available from: http://www.who.int/tb/publications/2012/tb_hiv_policy_9789241503006/en/ - PubMed
- 5. World Health Organization. WHO policy on collaborative TB/HIV activities: guidelines for national programmes and other stakeholders. Geneva: WHO; 2012. Available from: http://www.who.int/tb/publications/2012/tb_hiv_policy_9789241503006/en/ Accessed on 25 January 2016. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical